Future Medicine Co., Ltd. (XKON: 341170)
South Korea
· Delayed Price · Currency is KRW
1,900.00
0.00 (0.00%)
At close: Sep 10, 2024
Future Medicine Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
TTM
| FY 2021 | FY 2020 | FY 2019 |
Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue | 1,000 | 1,000 | - | - |
Cost of Revenue | - | - | - | 26.94 |
Gross Profit | 1,000 | 1,000 | - | -26.94 |
Selling, General & Admin | 1,834 | 1,860 | 1,693 | 1,998 |
Research & Development | 5,791 | 5,375 | 3,881 | 4,846 |
Other Operating Expenses | 16.65 | 16.65 | 3.98 | - |
Operating Expenses | 8,089 | 7,680 | 5,901 | 7,135 |
Operating Income | -7,089 | -6,680 | -5,901 | -7,162 |
Interest Expense | -1,559 | -1,555 | -1,617 | -1,095 |
Interest & Investment Income | 54.66 | 49.9 | 35.9 | 61.64 |
Currency Exchange Gain (Loss) | -1.23 | -2.9 | -0.95 | -0.01 |
Other Non Operating Income (Expenses) | -4,771 | -4,812 | -3,019 | -2,461 |
EBT Excluding Unusual Items | -13,365 | -13,000 | -10,502 | -10,656 |
Gain (Loss) on Sale of Assets | -1.42 | -1.42 | - | -15.64 |
Asset Writedown | - | - | - | -30 |
Pretax Income | -13,367 | -13,001 | -10,502 | -10,702 |
Net Income | -13,367 | -13,001 | -10,502 | -10,702 |
Net Income to Common | -13,367 | -13,001 | -10,502 | -10,702 |
Shares Outstanding (Basic) | 8 | 8 | 6 | 6 |
Shares Outstanding (Diluted) | 8 | 8 | 6 | 6 |
Shares Change (YoY) | - | 16.65% | 6.70% | - |
EPS (Basic) | -1637.42 | -1721.79 | -1622.43 | -1763.99 |
EPS (Diluted) | -1637.42 | -1721.79 | -1622.43 | -1764.00 |
Free Cash Flow | -7,205 | -6,686 | -4,300 | -7,046 |
Free Cash Flow Per Share | -882.61 | -885.51 | -664.32 | -1161.34 |
Gross Margin | 100.00% | 100.00% | - | - |
Operating Margin | -708.92% | -668.02% | - | - |
Profit Margin | -1336.67% | -1300.12% | - | - |
Free Cash Flow Margin | -720.50% | -668.64% | - | - |
EBITDA | -6,642 | -6,252 | -5,578 | -6,871 |
D&A For EBITDA | 447.28 | 428.34 | 322.39 | 290.92 |
EBIT | -7,089 | -6,680 | -5,901 | -7,162 |
Source: S&P Capital IQ. Standard template.
Financial Sources.